GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,991.00
Bid: 1,989.00
Ask: 1,991.00
Change: 7.00 (0.35%)
Spread: 2.00 (0.101%)
Open: 1,988.00
High: 1,992.00
Low: 1,975.00
Prev. Close: 1,984.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Merill Lynch Cuts Tesco To Underperform

Mon, 17th Mar 2014 10:07

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BERENBERG CUTS SSE PRICE TARGET TO 1320 (1570) PENCE - 'HOLD'
----------
BERENBERG CUTS REED ELSEVIER TO 'HOLD' ('BUY') - TARGET 930 (895) PENCE
----------
MERRILL LYNCH CUTS TESCO TO 'UNDERPERFORM' ('NEUTRAL')
----------
NOMURA RAISES BURBERRY PRICE TARGET TO 1650 (1630) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES SHELL PRICE TARGET TO 2450 (2350) PENCE - 'OUTPERFORM'
----------
CITIGROUP RAISES WOLSELEY PRICE TARGET TO 3660 (3596) PENCE - 'BUY'
----------
EXANE BNP RAISES ASTRAZENECA PRICE TARGET TO 3500 (3200) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES SHIRE PRICE TARGET TO 3600 (3100) PENCE - 'OUTPERFORM'
----------
Jefferies Raises Next Price Target To 7,500p From 7,000p - Buy
----------
LIBERUM CUTS WPP PRICE TARGET TO 1280 (1600) PENCE - 'HOLD'
----------
BARCLAYS RAISES STANDARD LIFE PRICE TARGET TO 377 (349) PENCE - 'EQUAL WEIGHT'
----------
FTSE 250
----------
BARCLAYS RAISES MICRO FOCUS TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
CITIGROUP CUTS BWIN.PARTY TO 'SELL' ('NEUTRAL') - TARGET 95 (125) PENCE
----------
UBS RAISES BALFOUR BEATTY PRICE TARGET TO 260 (250) PENCE - 'SELL'
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 1600 (1750) PENCE - 'BUY'
----------
CITIGROUP RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 1800 (1700) P. - 'BUY'
----------
JPMORGAN RAISES BODYCOTE PRICE TARGET TO 655 (540) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES RPS GROUP PRICE TARGET TO 351 (341) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS REGUS PLC PRICE TARGET TO 174 (177) PENCE - 'UNDERWEIGHT'
----------
BERNSTEIN RAISES HOME RETAIL TO 'MARKET-PERFORM' ('UNDERPERFORM.') - PT 190 (140) PENCE.
----------
BARCLAYS INITIATES COMPUTACENTER WITH 'UNDERWEIGHT' - TARGET 600 PENCE
----------
JEFFERIES RAISES COMPUTACENTER PRICE TARGET TO 720 (470) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
PANMURE RAISES HELLENIC CARRIERS PRICE TARGET TO 60 (50) PENCE - 'BUY'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.